Skip to content
OpenCapital
Get started

Co-Diagnostics, Inc. CODX Q4 2024 Annual earnings

Reported March 27, 2025 · After market close

Revenue$149.3KMiss by $225.7KDiluted EPS-$0.36Miss by $0.02
Revenue estimate$375.0K
EPS estimate-$0.34

Next report

Aug 14, 2026 (in a month)
Revenue estimate$132.6K
EPS estimate-$3.00

Versus estimates

Revenue

Q1 2026$146.0KBeat by $18.9KQ4 2025$262.5KBeat by $136.6KQ3 2025$145.4KBeat by $19.4KQ2 2025$162.9KMiss by $137.1KQ1 2025$50.3KMiss by $137.2K
Q4 2024$149.3KMiss by $225.7K

Diluted EPS

Q1 2026-$4.06Miss by $0.31Q4 2025-$16.35Miss by $12.75Q3 2025-$4.80Beat by $0.91Q2 2025-$0.23Beat by $0.02Q1 2025-$0.24Beat by $0.09
Q4 2024-$0.36Miss by $0.02

Ask the moment Co-Diagnostics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Co-Diagnostics, Inc. report Q4 2024 earnings?
Co-Diagnostics, Inc. (CODX) reported Q4 2024 earnings on March 27, 2025 after market close.
What were Co-Diagnostics, Inc. 's Q4 2024 revenue and EPS?
Co-Diagnostics, Inc. reported revenue of $149.3K and diluted EPS of $-0.36 for Q4 2024.
Did Co-Diagnostics, Inc. beat estimates in Q4 2024?
Revenue missed the consensus estimate of $375.0K by $225.7K. EPS missed the consensus estimate of $-0.34 by $0.02.
Where can I find Co-Diagnostics, Inc. 's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001641172-25-000932) directly on SEC EDGAR. The filing index links above go to sec.gov.